drugset / Trial / NCT06766474

The Rule of Bupivacaine Hydrochloride in Skin Graft Donor Site

NCT06766474

Phase 2 Completed 90 enrolled Minia University
RandomizedParallel-groupDouble-blindTreatment

Summary

Split Thickness Skin Graft is frequently utilized for reconstructing skin loss of various causes. Unfortunately, the donor site of the STSG has an unavoidable, annoying post-operative pain

Timeline

Start
2023-03-01
Primary completion
2024-10-15
Completion
2024-10-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupivacaine Other / unclassified Topical

Indications

No indication recorded.